HSV-TK converts non-toxic ganciclovir (GCV) into phosphorylated toxic compound (GCV-ppp) whereas CD modifides low-toxic substrat 5-fluorocytosine into a 5-fluorouracil potent anticancer agent, in both cases MSCs delivery efficiently these genes in tumor sites. Here, TKT is linked to neoplasm.